Dihydromyricetin inhibits migration and invasion of human breast cancer cells by suppressing mTOR signaling pathway

Hui CHANG; Junli CHEN; Yeyun GU; Mantian MI

doi:10.16016/j.1000-5404.201803135

您当前的位置：

首页 >

文章列表页 >

Dihydromyricetin inhibits migration and invasion of human breast cancer cells by suppressing mTOR signaling pathway

Military Medicine | 更新时间：2026-01-09

- Dihydromyricetin inhibits migration and invasion of human breast cancer cells by suppressing mTOR signaling pathway
- Journal of Third Military Medical University Vol. 40, Issue 18, Pages: 1624-1629(2018)
- 作者机构：
  
  1.400038 重庆，陆军军医大学(第三军医大学)军事预防医学系军队营养与食品卫生学教研室，重庆市营养与食品安全重点实验室，重庆市医学营养研究中心
  2.400715 重庆，西南大学食品科学学院
  3.100094 北京，中国航天员科研训练中心营养与食品工程重点实验室
- 作者简介：
- 基金信息：
  
  the Chongqing Fundamental and Frontier Science Research Project(CSTC 2017jcyjAX0088)
- DOI：10.16016/j.1000-5404.201803135
  CLC： R735.2
- Received：19 March 2018，
  
  Revised：2018-05-23，
  
  Published：30 September 2018
- 稿件说明：
移动端阅览
Hui CHANG, Junli CHEN, Yeyun GU, et al. Dihydromyricetin inhibits migration and invasion of human breast cancer cells by suppressing mTOR signaling pathway[J]. Journal of Third Military Medical University, 2018, 40(18): 1624-1629.
DOI：

Hui CHANG, Junli CHEN, Yeyun GU, et al. Dihydromyricetin inhibits migration and invasion of human breast cancer cells by suppressing mTOR signaling pathway[J]. Journal of Third Military Medical University, 2018, 40(18): 1624-1629. DOI： 10.16016/j.1000-5404.201803135.

摘要

目的

探讨二氢杨梅素(dihydromyricetin，DHM)对人乳腺癌细胞迁移和侵袭的抑制作用及其可能的分子机制。

方法

以不同浓度DHM(0、10、20μmol/L和40 μmol/L)处理乳腺癌细胞MDA-MB-231，采用Transwell实验检测DHM对癌细胞迁移和侵袭能力的影响，采用蛋白印迹法检测迁移与侵袭标志蛋白(Snail、vimentin、MMP-2和MMP-9)及抑迁移蛋白E-cadherin表达的变化；同时利用乳腺癌细胞裸鼠移植瘤模型和免疫组织化学检测法，观察DHM膳食干预(100 mg/kg)对体内癌细胞迁移与侵袭相关蛋白表达的影响。

结果

DHM处理乳腺癌细胞24 h，与对照组相比，细胞迁移和侵袭能力均显著降低(

0.05)，40 μmol/L处理组细胞迁移能力下降至(37.8±3.1)%，侵袭能力下降至(21.4±2.3)%；蛋白表达检测结果显示，DHM处理细胞其Snail、vimentin、MMP-2和MMP-9表达水平显著降低(

0.01)，40 μmol/L处理组蛋白表达分别下降至(31.2±2.9)%、(11.1±0.9)%、(14.4±1.2)%、(12.7±1.1)%，而E-cadherin表达水平显著升高(

0.01)，升高至(3.9±0.4)倍；体内研究结果也显示，DHM膳食干预可显

著降低移植瘤组织内Snail、vimentin和MMP-9的表达，提高E-cadherin的表达(

0.01)。进一步研究表明，DHM处理细胞24 h，与对照组相比，细胞内p-mTOR、p-4EBP1、p-S6K70和p-eIF4B表达水平均显著降低(

0.05)，表明其mTOR信号通路被显著抑制。

结论

DHM可有效抑制乳腺癌细胞的迁移和侵袭，其机制可能是通过抑制mTOR信号通路实现的。

Abstract

Objective

To investigate the effect of dihydromyricetin (DHM) on the migration and invasion in human breast cancer cells and explore the possible molecular mechanism.

Methods

Human breast cancer MDA-MB-231 cells were treated with 0

20 or 40 μmol/L DHM

and the changes in the migration and invasion of the cells were evaluated using Transwell assay. The expressionlevels of Snail

vimentin

MMP-2

MMP-9 and E-cadherin in the cells were detected by Western blotting. In nude mice bearing MDA-MB-231 cell xenograft

the effect of gastric lavage of 100 mg/kg DHM on the expression levels of these proteins in the tumor was investigated using immunohistochemistry.

Results

DHM treatment for 24 h effectively inhibited the migration and invasion of breast cancer cells(

0.05) with the dose of 40 μmol/L decreasing the migration to (37.8±3.1)% and the invasion to (21.4±2.3)%. Compared with the control cells

the DHM-treated cells exhibited significantly decreased expression of Snail

vimentin

MMP-2 and MMP-9 (

0.01) and an increased expression of E-cadherin(the dose increasing by 3.9±0.4 times). In the tumor-bearing mice

gastric lavage of DHM significantly down-regulated the expression of Snail

vimentin and MMP-9 and increased the expression of E-cadherin in the cells xenograft (

0.01). Treatment of MDA-MB-231 cells with DHM for 24 h also obviously reduced the phosphorylation of the downstream proteins

including mTOR

4EBP1

S6K70 and eIF4B(

0.05)

indicating the suppression of the activati

on of the mammalian target of rapamycin (mTOR) pathway.

Conclusion

DHM can significantly inhibit the migration and invasion of breast cancer cells possibly by suppressing the mTOR signaling pathway.

关键词

Keywords

references

SIEGEL R L, MILLER K D, JEMAL A. Cancer statistics, 2017[J]. CA Cancer J Clin, 2017, 67(1): 7-30. DOI: 10.3322/caac.21387.

水峥嵘, 唐雪元. GP73通过p53信号通路调节乳腺癌细胞MCF-7的增殖和凋亡[J].第三军医大学学报, 2018, 40(01): 64-69. DOI: 10.16016/j.1000-5404. 201708074.

SHUI Z R, TANG X Y. GP73 regulates proliferation and apoptosis of breast cancer MCF-7 via p53 signaling pathway[J]. J Third Mil Med Univ, 2018, 40(01): 64-69. DOI: 10.16016/j.1000- 5404.201708074.

黄哲宙, 陈万青, 吴春晓, 等.北京、上海、林州和启东地区女性乳腺癌发病及死亡的时间趋势[J].肿瘤, 2012, 32(8): 605-608. DOI: 10.3781/j.issn.1000-7431.2012.08.007.

HUANG Z Z, CHEN W Q, WU C X, et al . The trends of fema le breast cancer incidence and mortality in Beijing, Shanghai, Linzhou and Qidong in China[J ] . Tumor, 2012, 32(8): 605-608. DOI: 10.3781/j.issn.1000-7431. 2012.08.007.

DESANTIS C E, MA J, GODING SAUER A, et al . Breast cancer statistics, 2017, racial disparity in mortality by state[J ] . CA Cancer J Clin, 2017, 67(6): 439-448. DOI:10.3322/caac.21412.

LU X, YAN C, HUANG Y, et al . Mouse double minute 2 (MDM2) upregulates snail expression and induces epithelial-to-mesenchymal transition in breast cancer cells in vitro and in vivo [J ] . Oncotarget, 2016, 7(24): 37177-37191. DOI: 10. 18632/oncotarget.9287.

CHOI B J, PARK S A, LEE S Y, et al . Hypoxia induces epithelial-mesenchymal transition in colorectal cancer cells through ubiquitin-specific protease 47-mediated stabilization of snail: a potential role of sox9[J ] . Sci Rep, 2017, 7(1): 15918. DOI: 10.1038/s41598-017-15139-5.

GONZÁLEZ-CHAVARRÍA I, FERNANDEZ E, GUTIERREZN, et al . LOX-1 activation by oxLDL triggers an epithelial mesenchymal transition and promotes tumorigenic potential in prostate cancer cells[J ] . Cancer Lett, 2018, 414: 34-43. DOI: 10.1016/j.canlet.2017.10.035.

YU M, XUE H, WANG Y, et al . miR-345 inhibits tumor metastasis and EMT by targeting IRF1-mediated mTOR/STAT3/AKT pathway in hepatocellular carcinoma[J ] . Int J Oncol, 2017, 50(3): 975-983. DOI: 10.3892/ijo.2017.3852.

NIU P G, ZHANG Y X, SHI D H, et al . Cardamonin inhibits metastasis of lewis lung carcinoma cells by decreasing mTOR activity[J ] . PLoS ONE, 2015, 10(5): e0127778. DOI:10.1371/journal.pone. 0127778.

FAN K J, YANG B, LIU Y, et al . Inhibition of human lung cancer proliferation through targeting stromal fibroblasts by dihydromyricetin[J ] . Mol Med Rep, 2017, 16(6): 9758-9762. DOI: 10.3892/mmr.2017.7802.

XU Y, WANG S, CHAN H F, et al . Dihydromyricetin induces apoptosis and reverses drug resistance in ovarian cancer cells by p53-mediated downregulation of survivin[J ] . Sci Rep, 2017, 7: 46060. DOI: 10.1038/srep46060.

WANG Z, SUN X, FENG Y, et al . Dihydromyricetin reverses MRP2-mediated MDR and enhances anticancer activity induced by oxaliplatin in colorectal cancer cells[J ] . Anticancer Drugs, 2017, 28(3): 281-288. DOI: 10.1097/CAD. 0000000000000459.

RIZWANULLAH M, AMIN S, MIR S R, et al . Phytoche-mical based nanomedicines against cancer: current status and future prospects[J ] . J Drug Target, 2017: 1-22. DOI: 10.1080/1061186X.2017.1408115.

CHIKARA S, NAGAPRASHANTHA L D, SINGHAL J, et al . Oxidative stress and dietary phytochemicals: role in cancer chemoprevention and treatment[J ] . CancerLett, 2018, 413: 122-134. DOI: 10.1016/j.canlet.2017.11.002.

ZHU W, DU Y, MENG H, et al . A review of traditional pharmacological uses, phytochemistry, and pharmacological activities of tribulus terrestris [J ] . Chem Cent J, 2017, 11(1): 60. DOI: 10.1186/s13065-017-0289-x.

雷华平, 冯纪南, 任名新, 等.不同季节的显齿蛇葡萄中二氢杨梅素和总黄酮的含量测定[J].中国野生植物资源, 2017, 36(1): 37-39. DOI: 10.3969/j.issn.1006-9690.2017. 01.011.

LEI H P, FENG J N, REN M X, et al . Determination of dihydromyricetin and total flavones in ampelopis grossedentata in different seasons [J ] . Chin Wild Plant Resources, 2017, 36(1): 37-39. DOI: 10.3969/j.issn.1006-9690.2017. 01.011.

TAO Y, YANG S, WU Y, et al . MicroRNA-216a inhibits the metastasis of gastric cancer cells by targeting JAK 2/STAT3-mediated EMT process[J ] . Oncotarget, 2017, 8(51): 88870-88881. DOI: 10. 18632/oncotarget.21488.

WANG N, LI Y, ZHOU J. miR-31 functions as an oncomir which promotes epithelial-mesenchymal transition via regulating BAP1 in cervical cancer[J]. Biomed Res Int, 2017, 2017: 6361420. DOI: 10.1155/2017/6361420.

SHIN D H, KWON G S. Pre-clinical evaluation of a themo-sensitive gel containing epothilone B and mTOR/Hsp90 targeted agents in an ovarian tumor model[J]. J Control Release, 2017, 268: 176-183. DOI: 10.1016/j.jconrel.2017.10.022.

XU S, GE J, ZHANG Z, et al . MiR-129 inhibits cell prolife-ration and metastasis by targeting ETS1 via PI3K/AKT/mTOR pathway in prostate cancer[J ] . Biomed Pharmacother, 2017, 96: 634-641. DOI: 10.1016/j.biopha.2017.10.037.

PEI Z, FU W, WANG G. A natural product toosendanin inhibits epithelial-mesenchymal transition and tumor growth in pancreatic cancer via deactivating Akt/mTOR signaling[J]. Biochem Biophys Res Commun, 2017, 493(1): 455-460. DOI: 10.1016/j.bbrc.2017.08.170.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Effect of transmembrane protein 196 on migration and invasion of breast cancer

Heregulin-β1 promotes proliferation, migration and invasion of breast cancer cells by inducing stearoyl-CoA desaturase-1

Effects of LncRNA FGD5-AS1 on migration and invasion of gastric cancer cells by regulating miR-302b-3p/E2F1 axis

Expression of β-arrestin1 in oral squamous cell carcinoma and its effect on cell proliferation, migration and invasion

Mechanism of CPNE3 regulating proliferation, migration and invasion of non-small cell lung cancer cells

Related Author

张哲

樊俊

刘文斌

徐琰

陈璟若

马雪娇

吕思楠

安琪尔

Related Institution

Endoscopy Center, Qingdao Central Hospital of Rehabilitation University

Department of Gastroenterology, Qingdao Central Hospital of Rehabilitation University

School of Medicine， Shihezi University

Department of Stomatology， the First Affiliated Hospital of Shihezi University

Department of Pulmonary and Critical Care Medicine, Institute of Respiratory Diseases, the First Affiliated Hospital of Soochow University, Suzhou, Jiangsu Provmce

⁰